Company / AR per Share
BIOCRYST PHARMACEUTICALS INC AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.49
FY2025
5-year range
$0.16 / $0.49
FY2021-FY2025
Trend
+27.7%
vs FY2024
Sector context
#66 of 115
Health Care
What the data says
At $0.49, BIOCRYST PHARMACEUTICALS INC's ar per share ranks #66 of 115 in the Health Care sector. AR per Share has increased for 5 consecutive years, from $0.05 in FY2020 to $0.49 in FY2025.
Based on SEC 10-K filings.
0.49 in FY2025 with a 5-year CAGR of +56.7%.
Improved from $0.30 to $0.49 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +21.5%
- 5-Year CAGR
- +56.7%
- 10-Year CAGR
- -
Sector benchmark
#66 of 115 in Health CareTop 57% of 115This company $0.49 Sector average $27.05
▼
-98.2% below sector average
Key checks
Key Insights
- BIOCRYST PHARMACEUTICALS INC's ar per share has grown for 5 consecutive years.
- In FY2025, ar per share increased 27.7% year-over-year.
- Ranks #66 out of 115 companies in the Health Care sector.
- Lowest ar per share in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.49 | +27.7% |
| FY2024 | $0.38 | +29.1% |
| FY2023 | $0.30 | +8.9% |
| FY2022 | $0.27 | +65.7% |
| FY2021 | $0.16 | +217.7% |
| FY2020 | $0.05 | -73.0% |
| FY2019 | $0.19 | +360.5% |
| FY2018 | $0.04 | -49.8% |
| FY2017 | $0.08 | -30.6% |
| FY2016 | $0.12 | +37.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026